The interaction of alpha-mangostin and its derivatives against main protease enzyme in COVID-19 using in silico methods

More than 111 million people worldwide have been affected by the COVID-19 outbreak caused by SARS-CoV-2. The main therapeutic target of COVID-19 is main protease (Mpro). It plays a key role as an enzyme in the SARS-CoV-2 replication and transcription. In this case, the alpha-mangostin potentially ha...

Descripción completa

Detalles Bibliográficos
Autores principales: Hidayat, Syahrul, Ibrahim, Faisal Maulana, Pratama, Kelvin Fernando, Muchtaridi, Muchtaridi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8300326/
https://www.ncbi.nlm.nih.gov/pubmed/34345609
http://dx.doi.org/10.4103/japtr.JAPTR_299_20

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8300326/
https://www.ncbi.nlm.nih.gov/pubmed/34345609
http://dx.doi.org/10.4103/japtr.JAPTR_299_20

Ejemplares similares